Research | UT Southwestern Medical Center

×

CancerAnswers@Simmons

Research

AXL Inhibition Restores Response to PD-1 Blockade in STK11/LKB1-mutant NSCLC

Lung Cancer; Research

AXL Inhibition Restores Response to PD-1 Blockade in STK11/LKB1-mutant NSCLC

August 15, 2022

Latest

Four Prominent Research Projects with Therapeutic Implications Take Shape

Four Prominent Research Projects with Therapeutic Implications Take Shape

February 1, 2022

New Nanotechnology Allows Tissue-Specific Delivery of Genomic Medicines

New Nanotechnology Allows Tissue-Specific Delivery of Genomic Medicines

April 30, 2021

ChIA-PET Sequencing Provides Insight into Prostate Cancer Genomics

ChIA-PET Sequencing Provides Insight into Prostate Cancer Genomics

April 29, 2021

Cellular Stress Response Promotes Immune Evasion in Lung Cancer

Cellular Stress Response Promotes Immune Evasion in Lung Cancer

October 26, 2020

Novel Drug Combination Fights Resistance to TKI Therapy

Novel Drug Combination Fights Resistance to TKI Therapy

October 26, 2020

Top Articles

Novel Biomarker Might Lead to Personalized, Targeted Therapy

Gynecologic Cancer; Research

Novel Biomarker Might Lead to Personalized, Targeted Therapy

ADP-ribosylation could help scientists predict PARP inhibitor sensitivity in ovarian and breast cancer patients. Learn how UT Southwestern is advancing this research.

Jayanthi Lea, M.D.

August 3, 2020

Adjuvant Chemotherapy for Stage III Colon Cancer in Healthy Patients

Gastrointestinal Cancer; Research

Adjuvant Chemotherapy for Stage III Colon Cancer in Healthy Patients

Researchers at UT Southwestern set out to understand the under-utilization of ACT in stage three colon cancer patients. Learn the impact on patient outcomes here.

September 18, 2020

All Articles

AXL Inhibition Restores Response to PD-1 Blockade in STK11/LKB1-mutant NSCLC

Lung Cancer; Research

AXL Inhibition Restores Response to PD-1 Blockade in STK11/LKB1-mutant NSCLC

August 15, 2022

Four Prominent Research Projects with Therapeutic Implications Take Shape

Four Prominent Research Projects with Therapeutic Implications Take Shape

February 1, 2022

New Nanotechnology Allows Tissue-Specific Delivery of Genomic Medicines

Cancer; Research

New Nanotechnology Allows Tissue-Specific Delivery of Genomic Medicines

Daniel Siegwart, Ph.D.

April 30, 2021

ChIA-PET Sequencing Provides Insight into Prostate Cancer Genomics

Genitourinary Cancer; Research

ChIA-PET Sequencing Provides Insight into Prostate Cancer Genomics

Ram Mani Ph.D.

April 29, 2021

Cellular Stress Response Promotes Immune Evasion in Lung Cancer

Lung Cancer; Research

Cellular Stress Response Promotes Immune Evasion in Lung Cancer

Kathryn O'Donnell, Ph.D.

October 26, 2020

Novel Drug Combination Fights Resistance to TKI Therapy

Lung Cancer; Research

Novel Drug Combination Fights Resistance to TKI Therapy

Amyn Habib, M.D.

October 26, 2020

Adjuvant Chemotherapy for Stage III Colon Cancer in Healthy Patients

Gastrointestinal Cancer; Research

Adjuvant Chemotherapy for Stage III Colon Cancer in Healthy Patients

September 18, 2020

Novel Biomarker Might Lead to Personalized, Targeted Therapy

Gynecologic Cancer; Research

Novel Biomarker Might Lead to Personalized, Targeted Therapy

Jayanthi Lea, M.D.

August 3, 2020